Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Phytochemistry ; 63(1): 97-104, 2003 May.
Artigo em Inglês | MEDLINE | ID: mdl-12657303

RESUMO

Four aqueous extracts from different parts of medicinal plants used in Ayurveda (an ancient Indian Medicine) viz., Momardica charantia Linn (AP1), Glycyrrhiza glabra (AP2), Acacia catechu (AP3), and Terminalia chebula (AP4) were examined for their potential as antioxidants. The antioxidant activity of these extracts was tested by studying the inhibition of radiation induced lipid peroxidation in rat liver microsomes at different doses in the range of 100-600 Gy as estimated by thiobarbituric acid reactive substances (TBARS). Of all these extracts, AP4 showed maximum inhibition in the TBARS formation and hence is considered the best antioxidant among these four extracts. The extracts were found to restore antioxidant enzyme superoxide dismutase (SOD) from the radiation induced damage. The antioxidant capacities were also evaluated in terms of ascorbate equivalents by different methods such as cyclic voltammetry, decay of ABTS(.-) radical by pulse radiolysis and decrease in the absorbance of DPPH radicals. The results were found to be in agreement with the lipid peroxidation data and AP4 showed maximum value of ascorbate equivalents. Therefore AP4, with high antioxidant activity, is considered as the best among these four extracts.


Assuntos
Antioxidantes/análise , Antioxidantes/farmacologia , Ayurveda , Plantas Medicinais/química , Animais , Ácido Ascórbico/química , Compostos de Bifenilo , Relação Dose-Resposta a Droga , Eletroquímica/métodos , Radicais Livres/química , Radicais Livres/metabolismo , Raios gama , Concentração Inibidora 50 , Cinética , Peroxidação de Lipídeos/efeitos dos fármacos , Peroxidação de Lipídeos/efeitos da radiação , Microssomos Hepáticos/efeitos dos fármacos , Microssomos Hepáticos/efeitos da radiação , Mitocôndrias Hepáticas/efeitos dos fármacos , Mitocôndrias Hepáticas/efeitos da radiação , Picratos/química , Extratos Vegetais/farmacologia , Radiólise de Impulso/métodos , Ratos , Superóxido Dismutase/metabolismo , Substâncias Reativas com Ácido Tiobarbitúrico/análise , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismo
2.
J Ethnopharmacol ; 88(1): 107-11, 2003 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12902059

RESUMO

Momordica charantia (L.) (Cucurbitaceae) commonly known as bitter gourd or karela is a medicinal plant, used in Ayurveda for treating various diseases, one of which is diabetes mellitus. In this study, various extract powders of the fresh and dried whole fruits were prepared and their blood glucose lowering effect compared by administrating them orally to diabetic rats. The aqueous extract powder of fresh unripe whole fruits at a dose of 20mg/kg body weight was found to reduce fasting blood glucose by 48%, an effect comparable to that of glibenclamide, a known synthetic drug. This extract was tested for nephrotoxicity, hepatotoxicity and biochemical parameters such as SGOT, SGPT and lipid profile. The extract did not show any signs of nephrotoxicity and hepatotoxicity as judged by histological and biochemical parameters. Thus the aqueous extract powder of Momordica charantia, an edible vegetable, appears to be a safe alternative to reducing blood glucose.


Assuntos
Hipoglicemiantes/uso terapêutico , Momordica , Fitoterapia , Extratos Vegetais/uso terapêutico , Aloxano/efeitos adversos , Estruturas Animais/química , Estruturas Animais/efeitos dos fármacos , Animais , Glicemia/efeitos dos fármacos , Glicemia/metabolismo , Peso Corporal/efeitos dos fármacos , Diabetes Mellitus Experimental/induzido quimicamente , Diabetes Mellitus Experimental/tratamento farmacológico , Diabetes Mellitus Experimental/prevenção & controle , Modelos Animais de Doenças , Esquema de Medicação , Frutas , Glibureto/farmacologia , Glibureto/uso terapêutico , Hipoglicemiantes/química , Hipoglicemiantes/farmacologia , Índia , Masculino , Ayurveda , Extratos Vegetais/química , Extratos Vegetais/farmacologia , Ratos , Ratos Wistar , Solventes
3.
Indian J Exp Biol ; 39(6): 511-9, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12562011

RESUMO

Phytoestrogens represent a family of plant compounds such as isoflavones, flavones and lignans. A variety of these plant compounds have been identified in various human body fluids. A wide range of commonly consumed foods contains appreciable amounts of these different phytoestrogens, viz. soy products are particularly good sources of isoflavones and lignans. Accumulating evidences from molecular and cellular biology experiments, animal studies, and to a limited extent, human clinical trials suggests that phytoestrogens may potentially confer health benefits related to various cancers and diseases such as cardiovascular disorder. The evidences reviewed here represent the beneficial effects of most potential and promising isoflavone, Genistein in various types of cancers.


Assuntos
Antineoplásicos Fitogênicos/farmacologia , Genisteína/farmacologia , Animais , Antineoplásicos Fitogênicos/isolamento & purificação , Genisteína/isolamento & purificação , Humanos , Glycine max/química
4.
Indian J Exp Biol ; 39(6): 520-5, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12562012

RESUMO

Phytoestrogens represent a family of plant compounds such as isoflavones, flavones and lignans. A wide range of commonly consumed foods contains appreciable amounts of different phytoestrogens such as isoflavones and lignans. Soy and its products are particularly good sources of isoflavones and lignans. The evidence reviewed here represents the beneficial effects of most potential and promising isoflavone, Genistein in various types of diseases such as osteoporosis, cardiovascular diseases, menopausal symptoms by accumulating evidence from molecular and cellular biology experiments, animal studies, and, to a limited extent, human clinical trials. This review suggests that phytoestrogens may potentially confer health benefits related to various diseases such as cardiovascular disorder, menopausal symptoms, and osteoporosis.


Assuntos
Anticolesterolemiantes/farmacologia , Genisteína/farmacologia , Glycine max/química , Menopausa , Osteoporose/tratamento farmacológico , Feminino , Genisteína/efeitos adversos , Genisteína/farmacocinética , Genisteína/uso terapêutico , Humanos
5.
J Assoc Physicians India ; 39(7): 546-8, 1991 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-1800501

RESUMO

The objective of the study was to compare the enteric coated diclofenac sodium (Voveran), the slow release formulation developed in India (Voveran SR) and the internationally marketed formulation Voltaren Retard. Ten healthy volunteers were administered 100 mg each of the three formulations in a three-way crossover fashion. Blood samples were collected over 24 hours following administration of the drug; plasma levels of unchanged drug were determined by gas chromatography. Pharmacokinetic parameters for the three formulations were compared. The extent of the drug available from the three formulations was the same as the mean AUC values were not significantly different. Cmax and MRT values for the two slow release formulations were comparable but were significantly different from the values obtained with the enteric coated formulation. Tmax values for the two slow release formulations were similar while the enteric coated tablet had faster time to peak. Voveran SR is comparable to Voltaren Retard and has the distinct advantage of a slow release formulation in that its Cmax is much lower and levels are maintained over 12 hours and detectable upto 24 hours. This slow release formulation will offer clinical advantages of better compliance, relief of early morning symptoms and better tolerability over long term usage.


Assuntos
Diclofenaco/farmacocinética , Adulto , Disponibilidade Biológica , Preparações de Ação Retardada , Diclofenaco/administração & dosagem , Diclofenaco/sangue , Humanos , Masculino , Pessoa de Meia-Idade , Comprimidos com Revestimento Entérico , Fatores de Tempo
7.
Phytother Res ; 19(7): 582-6, 2005 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16161061

RESUMO

The aqueous extract of the fruits of Emblica officinalis (T1), Terminalia chebula (T2) and Terminalia belerica (T3) and their equiproportional mixture triphala were evaluated for their in vitro antioxidant activity. gamma-Radiation induced strand break formation in plasmid DNA (pBR322) was effectively inhibited by triphala and its constituents in the concentration range 25-200 microg/mL with a percentage inhibition of T1 (30%-83%), T2 (21%-71%), T3 (8%-58%) and triphala (17%-63%). They also inhibited radiation induced lipid peroxidation in rat liver microsomes effectively with IC(50) values less than 15 microg/mL. The extracts were found to possess the ability to scavenge free radicals such as DPPH and superoxide. As the phenolic compounds present in these extracts are mostly responsible for their radical scavenging activity, the total phenolic contents present in these extracts were determined and expressed in terms of gallic acid equivalents and were found to vary from 33% to 44%. These studies revealed that all three constituents of triphala are active and they exhibit slightly different activities under different conditions. T1 shows greater efficiency in lipid peroxidation and plasmid DNA assay, while T2 has greater radical scavenging activity. Thus their mixture, triphala, is expected to be more efficient due to the combined activity of the individual components.


Assuntos
Antioxidantes/farmacologia , Sequestradores de Radicais Livres/farmacologia , Fitoterapia , Extratos Vegetais/farmacologia , Plantas Medicinais , Animais , Antioxidantes/administração & dosagem , Antioxidantes/química , Antioxidantes/uso terapêutico , Compostos de Bifenilo , DNA/efeitos dos fármacos , Sequestradores de Radicais Livres/administração & dosagem , Sequestradores de Radicais Livres/química , Sequestradores de Radicais Livres/uso terapêutico , Concentração Inibidora 50 , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Ayurveda , Microssomos Hepáticos/efeitos dos fármacos , Phyllanthus emblica , Picratos/química , Extratos Vegetais/administração & dosagem , Extratos Vegetais/química , Extratos Vegetais/uso terapêutico , Ratos , Ratos Wistar , Superóxidos/química , Terminalia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA